Immutep (ASX: IMM) are global leaders in the understanding and development of therapeutics that relate to Lymphocyte Activation Gene-3 or “LAG-3” which is a cell surface molecule that plays a vital role in regulating the immune system. LAG-3 was discovered by our Chief Scientific Officer and Chief Medical Officer Dr. Frederic Triebel, putting Immutep at the forefront of immunotherapy drugs for cancer and autoimmune diseases.
Latest from Immutep (ASX: IMM) on LAG-3 and 2022 Outlook
The attached video covers biotech company Immutep's latest news on their Lymphocyte Activation Gene-3 (LAG-3) treatment and outlook for the coming 12 months.
- Published on December 15, 2021
- By Staff Writers
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- China unveils plan to boost consumption amid economic...March 17, 2025
- Capital Prudential Strengthens Governance With New DirectorsMarch 17, 2025
- INOVIQ appoints Dr Emma Ball as Chief Commercial OfficerMarch 17, 2025
- How immunotherapy works: Unlocking the power of the immune...March 17, 2025
- UBS Upgrades Mineral Resources to "Buy"March 17, 2025
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (75)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (7)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (55)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- Featured (43)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6112)
- Franklin Templeton (1)
- fresh grind (265)
- fundie guide (22)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (52)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (43)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (376)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18215)
- Stocks of the Hour (300)
- sip & learn (23)
- sip and learn (23)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (23)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (831)